HAEBRII Trademark

Trademark Overview

On Monday, June 30, 2025, a trademark application was filed for HAEBRII with the United States Patent and Trademark Office. The USPTO has given the HAEBRII trademark a serial number of 99260329. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 23, 2025. This trademark is owned by Pharvaris GmbH. The HAEBRII trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of rare and orphan diseases and disorders; pharmaceutical preparations for the treatment and prevention of hematological diseases and disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for the treatment and prevention of genetic diseases and disorders; pharmaceutical preparations for the treatment and prevention of hereditary angioedema (HAE); pharmaceutical preparations for the treatment and prevention of bradykinin mediated angioedema; pharmaceutical preparations for the treatment and prevention of acquired angioedema

Providing medical information to healthcare providers and patients relating to hematological, inflammatory, genetic, and rare diseases and disorders; providing medical information, namely, providing healthcare providers and patients with information regarding clinical research, clinical trials and studies, disease management resources, and access to pharmaceuticals for the treatment and prevention of hereditary angioedema
haebrii

General Information

Serial Number99260329
Word MarkHAEBRII
Filing DateMonday, June 30, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of rare and orphan diseases and disorders; pharmaceutical preparations for the treatment and prevention of hematological diseases and disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for the treatment and prevention of genetic diseases and disorders; pharmaceutical preparations for the treatment and prevention of hereditary angioedema (HAE); pharmaceutical preparations for the treatment and prevention of bradykinin mediated angioedema; pharmaceutical preparations for the treatment and prevention of acquired angioedema
Goods and ServicesProviding medical information to healthcare providers and patients relating to hematological, inflammatory, genetic, and rare diseases and disorders; providing medical information, namely, providing healthcare providers and patients with information regarding clinical research, clinical trials and studies, disease management resources, and access to pharmaceuticals for the treatment and prevention of hereditary angioedema

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 30, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePharvaris GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Monday, June 30, 2025NEW APPLICATION ENTERED
Monday, June 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 30, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, August 27, 2025ASSIGNED TO EXAMINER
Wednesday, August 27, 2025NON-FINAL ACTION WRITTEN
Wednesday, August 27, 2025NON-FINAL ACTION E-MAILED
Wednesday, August 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 14, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

haebrii treatment prevention pharmaceutical preparations disorders diseases angioedema information providing healthcare